Tin tức & Cập nhật

A phase II nonrandomized trial of trabectedin in combination with radiotherapy for the treatment of myxoid liposarcoma has failed to meet its endpoint, although this treatment combination appears to be well tolerated in patients.

Sarecycline demonstrated efficacy for the treatment of moderate-to-severe facial acne vulgaris in patients with skin of colour, according to a post hoc analysis of two phase III trials presented at AAD 2023.

When added to chemotherapy, disulfiram and copper do not appear to yield survival benefits in patients with recurrent glioblastoma, even leading to an increased frequency of adverse events, as shown in the results of an open-label, randomized phase II/III study.

Eribulin and trabectedin show significant antitumour activity in advanced pleomorphic liposarcoma as compared with conventional chemotherapy, according to retrospective data from the Gustave Roussy cancer centre presented at ESMO SARCOMA 2023.

Treatment with four-factor prothrombin complex concentrate (4F-PCC) appears safe and effective for patients with factor Xa inhibitor-associated bleeding events, suggests a recent study.

Treatment with apremilast showed clear or almost clear skin in paediatric patients with moderate-to-severe plaque psoriasis, according to the SPROUT study presented at AAD 2023.